MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The company also develops Pelabresib, a small molecule that is in Phase II clinical trial to treat myelofibrosis; Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease; and CPI-0209, a small molecule that is in Phase I/II designed to promote anti-tumor activity by inhibiting EZH2. In addition, it develops Gantenerumab, an antibody for the treatment of Alzheimer's diseases through its pharmaceutical partners; Otilimab, an antibody for rheumatoid arthritis; Tremfya, an antibody to treat psoriasis, psoriatic arthritis, and palmoplantar pustulosis; and MOR210/TJ210, an antibody to treat immuno-oncology and autoimmune diseases. MorphoSys AG has a regional licensing agreement with I-Mab Biopharma to develop and commercialize felzartamab in China, Taiwan, Hong Kong, and Macau; a strategic alliance with the LEO Pharma; a joint collaboration and license agreement with Incyte Corporation to develop and commercialize MorphoSys investigational compound tafasitamab; and a clinical collaboration with Incyte Corporation and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was founded in 1992 and is headquartered in Planegg, Germany. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of MORPHOSYS AG O.N..
MORPHOSYS AG O.N. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of MORPHOSYS AG O.N. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of MORPHOSYS AG O.N. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of MORPHOSYS AG O.N. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of MORPHOSYS AG O.N. and all latest updates of the company are provided.
The 2025 version of MORPHOSYS AG O.N. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 MORPHOSYS AG O.N.- Key Facts
2.2 MORPHOSYS AG O.N.- Geographic Locations
2.3 MORPHOSYS AG O.N.- Subsidiaries and Affiliates
2.4 MORPHOSYS AG O.N.- Business Divisions
2.5 MORPHOSYS AG O.N.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. MORPHOSYS AG O.N. Strategic Analysis Review
3.1 MORPHOSYS AG O.N.- Key Strategies
3.2 MORPHOSYS AG O.N.- Company Outlook Statement
3.3 MORPHOSYS AG O.N.- SWOT Analysis
3.3.1 MORPHOSYS AG O.N.- Key Strengths
3.3.2 MORPHOSYS AG O.N.- Key Weaknesses
3.3.3 MORPHOSYS AG O.N.- Potential Opportunities
3.3.4 MORPHOSYS AG O.N.- Potential Threats
3.4 MORPHOSYS AG O.N.- Key Competitors
4. Business Description of the Company
4.1 MORPHOSYS AG O.N.- Business Overview
4.2 MORPHOSYS AG O.N.- Operations by Segment
5 Products and Services Details
5.1 MORPHOSYS AG O.N.- Key Products
5.2 MORPHOSYS AG O.N.- Key Service Areas
5.3 MORPHOSYS AG O.N.- Key Brands
6 Company Developments
6.1 MORPHOSYS AG O.N.- Company History
6.2 MORPHOSYS AG O.N.- Latest Developments
7 Financial Analysis
7.1 MORPHOSYS AG O.N.- Income Statements
7.2 MORPHOSYS AG O.N.- Balance Sheet
7.3 MORPHOSYS AG O.N.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 MORPHOSYS AG O.N.- Direct Competitors
8.2 MORPHOSYS AG O.N.- Competitor Financial Ratios comparison
8.3 MORPHOSYS AG O.N.- Competitor Stock Charts Comparison
8.4 MORPHOSYS AG O.N.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
